logo
Sign in

TMCI Stock Price, Chart, Stats & News

Treace Medical Concepts Inc
Save

Treace Medical Concepts Inc (TMCI) does not currently pay a dividend.

297.12M
Market cap
Current P/E
Forward P/E

TMCI chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
79.81%
Operating margin
-25.46%
Pretax margin
-27.74%
Net margin
-27.74%
Effective tax rate
ROA
-30.96%
ROE
-62.19%
D/E
0.16x
Interest coverage ratio
-10.18x

TMCI valuation

P/E
P/S
0.37x
P/B
0.89x
P/CF
-4.88x
P/FCF
-2.67x
P/OCF
-4.88x
PEG
0.08x
EV multiple
-1.76x

About

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant.

Similar securities

Based on sector and market capitalization

Report issue